tiprankstipranks
Elevation Oncology (ELEV)
NASDAQ:ELEV
US Market

Elevation Oncology (ELEV) Financial Statements

Compare
575 Followers

Elevation Oncology Financial Overview

Elevation Oncology's market cap is currently $15.58M. The company's EPS TTM is $-0.797; its P/E ratio is ―; Elevation Oncology is scheduled to report earnings on May 1, 2025, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -39.00K$ -27.00K$ -18.00K$ -15.00K
Operating Income$ -44.70M$ -45.45M$ -94.55M$ -32.05M$ -17.28M
EBITDA$ -44.70M$ -41.47M$ -94.52M$ -32.03M$ -17.25M
Net Income$ -44.48M$ -45.70M$ -95.08M$ -32.04M$ -17.27M
Balance Sheet
Cash & Short-Term Investments$ 93.18M$ 83.11M$ 90.28M$ 146.28M$ 79.40M
Total Assets$ 95.63M$ 89.09M$ 94.16M$ 149.49M$ 80.91M
Total Debt$ 31.13M$ 30.14M$ 29.43M$ 0.00$ 0.00
Net Debt$ -18.33M$ -19.12M$ -16.48M$ -146.28M$ -79.40M
Total Liabilities$ 35.60M$ 34.28M$ 45.13M$ 8.80M$ 103.99M
Stockholders' Equity$ 60.02M$ 54.81M$ 49.03M$ 140.70M$ -23.08M
Cash Flow
Free Cash Flow$ -36.36M$ -56.18M$ -85.57M$ -30.17M$ -12.37M
Operating Cash Flow$ -36.36M$ -56.18M$ -85.48M$ -30.17M$ -12.30M
Investing Cash Flow$ -8.37M$ 11.54M$ -44.40M$ 0.00$ -71.00K
Financing Cash Flow$ 44.94M$ 47.98M$ 29.51M$ 97.05M$ 90.03M
Currency in USD

Elevation Oncology Earnings and Revenue History

Elevation Oncology Debt to Assets

Elevation Oncology Cash Flow

Elevation Oncology Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis